U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07134816) titled 'Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder' on Feb. 04.
Brief Summary: The aim of the study is to assess the effectiveness and costs of a cognitive-behavioral treatment (CBT) for auditory hallucinations (psychotherapy) as an adjunct to usual care, comparing it to the effectiveness and costs of usual care alone. Usual care is defined as the use of medication, regular consultations with your psychiatrist, and, if necessary, day hospital care.
The study plans to include 240 participants across several hospitals in France (multicenter study). Each participant will be rando...